Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in breast cancer surgery
NCT04454515Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in breast cancer comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoint: Postoperative morphine consumption at 7 days. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04454515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454515.